Fingerprint
Dive into the research topics of 'Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer
Don S Dizon, Lars Damstrup, Neil J Finkler, Ulrik Lassen, Paul Celano, Ros Glasspool, Elizabeth Crowley, Henri S Lichenstein, Poul Knoblach, Richard T Penson